QH BIO PHARMA 00876Hong Kong Stock Exchange

1.82010.98%( +0.180 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
QH BIO PHARMA (00876) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
1997-04-10
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
BMG522112017

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)125.65M87/112
Net Profit (Last FY)-42.16M62/125

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
Kwok Ying Shing Executive Director
Luo Jun Executive Director
Luo Tingting Executive Director
Xie Binhong Executive Director
Yang Feng Executive Director
Ye Haoda Executive Director
Liu Yanwen Independent Non-Executive Director
Lyu Aiping Independent Non-Executive Director
Li Zhiying Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-07-13.

About this page

This page shows QH BIO PHARMA (00876) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.